1. Home
  2. MBIN vs SUPN Comparison

MBIN vs SUPN Comparison

Compare MBIN & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBIN
  • SUPN
  • Stock Information
  • Founded
  • MBIN 1990
  • SUPN 2005
  • Country
  • MBIN United States
  • SUPN United States
  • Employees
  • MBIN N/A
  • SUPN N/A
  • Industry
  • MBIN Major Banks
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • MBIN Finance
  • SUPN Health Care
  • Exchange
  • MBIN Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • MBIN 2.0B
  • SUPN 1.8B
  • IPO Year
  • MBIN 2017
  • SUPN 2012
  • Fundamental
  • Price
  • MBIN $31.61
  • SUPN $31.91
  • Analyst Decision
  • MBIN Buy
  • SUPN Hold
  • Analyst Count
  • MBIN 3
  • SUPN 2
  • Target Price
  • MBIN $47.50
  • SUPN $36.00
  • AVG Volume (30 Days)
  • MBIN 145.5K
  • SUPN 460.6K
  • Earning Date
  • MBIN 04-28-2025
  • SUPN 05-06-2025
  • Dividend Yield
  • MBIN 1.26%
  • SUPN N/A
  • EPS Growth
  • MBIN N/A
  • SUPN N/A
  • EPS
  • MBIN 5.44
  • SUPN 1.11
  • Revenue
  • MBIN $621,412,000.00
  • SUPN $667,997,000.00
  • Revenue This Year
  • MBIN $0.85
  • SUPN N/A
  • Revenue Next Year
  • MBIN $10.33
  • SUPN $8.74
  • P/E Ratio
  • MBIN $5.83
  • SUPN $28.64
  • Revenue Growth
  • MBIN 7.58
  • SUPN 11.82
  • 52 Week Low
  • MBIN $27.25
  • SUPN $25.53
  • 52 Week High
  • MBIN $53.27
  • SUPN $40.28
  • Technical
  • Relative Strength Index (RSI)
  • MBIN 44.37
  • SUPN 47.71
  • Support Level
  • MBIN $30.70
  • SUPN $31.56
  • Resistance Level
  • MBIN $32.98
  • SUPN $32.85
  • Average True Range (ATR)
  • MBIN 0.96
  • SUPN 0.78
  • MACD
  • MBIN 0.07
  • SUPN -0.08
  • Stochastic Oscillator
  • MBIN 30.54
  • SUPN 24.38

About MBIN Merchants Bancorp

Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and Banking segment that provides a wide range of financial products and services to consumers and businesses, including commercial and other consumer loan products.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: